Sage
AIAetherRx AI Guide
Disclaimer
AI Guide • Not Medical AdviceStrictly searching verified AetherRx forums, protocols, and botanicals.
AetherRx AI is an educational guide, not traditional advice.
AetherRx AI Guide
Strictly searching verified AetherRx forums, protocols, and botanicals.
AetherRx AI is an educational guide, not traditional advice.
Administration of high-dose oral ascorbic acid (Vitamin C: 6 to 18 grams daily to bowel tolerance) co-administered with therapeutic L-lysine and L-proline to bind lipoprotein(a) apoprotein binding sites, preventing arterial plaque deposition and restoring vessel collagen cross-linking.
Documented practitioner literature, published archives, and historic clinical citations
“Administration of high-dose oral ascorbic acid (Vitamin C: 6 to 18 grams daily to bowel tolerance) co-administered with therapeutic L-lysine and L-proline to bind lipoprotein(a) apoprotein binding sites, preventing arterial plaque deposition and restoring vessel collagen cross-linking.”
Community experiences, dosages, and questions for Liposomal Vitamin C in connection with Atherosclerosis
"Administration of high-dose oral ascorbic acid (Vitamin C: 6 to 18 grams daily to bowel tolerance) co-administered with therapeutic L-lysine and L-proline to bind lipoprotein(a) apoprotein binding sites, preventing arterial plaque deposition and restoring vessel collagen cross-linking."
You must be logged in to join the discussion.
Every new account includes a complimentary 1-year Oracle membership. Organize remedies in your personal wellness cabinet, contribute community protocols, and run unlimited queries in AI Sage.
"Administration of high-dose oral ascorbic acid (Vitamin C: 6 to 18 grams daily to bowel tolerance) co-administered with therapeutic L-lysine and L-proline to bind lipoprotein(a) apoprotein binding sites, preventing arterial plaque deposition and restoring vessel collagen cross-linking."
Administration of high-dose oral ascorbic acid (Vitamin C: 6 to 18 grams daily to bowel tolerance) co-administered with therapeutic L-lysine and L-proline to bind lipoprotein(a) apoprotein binding sites, preventing arterial plaque deposition and restoring vessel collagen cross-linking.
Core perspective shared by Linus Pauling (Linus Pauling Institute, Caltech): "Pauling Therapy: Megadoses of ascorbic acid combined with L-lysine and L-proline for vascular wall integrity" Key Works: Vitamin C and the Common Cold (1970), How to Live Longer and Feel Better (1986).
